Send the following on WhatsApp
Continue to Chathttps://nl.marketscreener.com/koers/aandeel/EMERGENT-BIOSOLUTIONS-INC-36547/nieuws/Emergent-BioSolutions-Inc-Presenteert-gegevens-van-fase-2-onderzoek-naar-de-veiligheid-en-immunogen-42173690/?utm_source=whatsapp&utm_medium=social&utm_campaign=share